

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.06176279 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.98645350 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.61441145 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.59458940 |
| 5 | glutamate secretion (GO:0014047) | 5.12156527 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.11654846 |
| 7 | vocalization behavior (GO:0071625) | 5.07621092 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.06118765 |
| 9 | regulation of memory T cell differentiation (GO:0043380) | 4.98575398 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.95126013 |
| 11 | regulation of establishment of cell polarity (GO:2000114) | 4.93914078 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.87900640 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.87342286 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.86046223 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.86046223 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.86046223 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.81482717 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.68029849 |
| 19 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.61695568 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.60889570 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.55875195 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.54054579 |
| 23 | negative regulation of multicellular organism growth (GO:0040015) | 4.52666000 |
| 24 | sex differentiation (GO:0007548) | 4.47974852 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.37079504 |
| 26 | protein localization to synapse (GO:0035418) | 4.36190513 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.36048925 |
| 28 | neuronal action potential propagation (GO:0019227) | 4.35384255 |
| 29 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.34439884 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.33417724 |
| 31 | exploration behavior (GO:0035640) | 4.24334018 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 4.22532544 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 4.21685954 |
| 34 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.19970704 |
| 35 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.08027329 |
| 36 | indolalkylamine metabolic process (GO:0006586) | 4.05981187 |
| 37 | tryptophan metabolic process (GO:0006568) | 4.05409044 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.97036658 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.96470639 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87678474 |
| 41 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.84707444 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.81596459 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.81334874 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.81271073 |
| 45 | neuron-neuron synaptic transmission (GO:0007270) | 3.77006996 |
| 46 | long-term memory (GO:0007616) | 3.76619390 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.75325355 |
| 48 | positive regulation of membrane potential (GO:0045838) | 3.71542481 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.71130505 |
| 50 | neuron cell-cell adhesion (GO:0007158) | 3.67202930 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 3.63920374 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.58749120 |
| 53 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.58055116 |
| 54 | prepulse inhibition (GO:0060134) | 3.53547490 |
| 55 | neuromuscular process controlling balance (GO:0050885) | 3.53483947 |
| 56 | indole-containing compound metabolic process (GO:0042430) | 3.53391292 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.49801148 |
| 58 | serotonin metabolic process (GO:0042428) | 3.49687058 |
| 59 | proline transport (GO:0015824) | 3.47597219 |
| 60 | neurotransmitter transport (GO:0006836) | 3.46260982 |
| 61 | behavioral response to ethanol (GO:0048149) | 3.45547085 |
| 62 | auditory behavior (GO:0031223) | 3.42991295 |
| 63 | transmission of nerve impulse (GO:0019226) | 3.42210198 |
| 64 | ADP metabolic process (GO:0046031) | 3.40227788 |
| 65 | auditory receptor cell stereocilium organization (GO:0060088) | 3.38715427 |
| 66 | regulation of action potential (GO:0098900) | 3.37933148 |
| 67 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36523787 |
| 68 | behavioral response to nicotine (GO:0035095) | 3.36392178 |
| 69 | fucose catabolic process (GO:0019317) | 3.36027677 |
| 70 | L-fucose metabolic process (GO:0042354) | 3.36027677 |
| 71 | L-fucose catabolic process (GO:0042355) | 3.36027677 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 3.34676910 |
| 73 | regulation of neurotransmitter levels (GO:0001505) | 3.34583165 |
| 74 | primary amino compound metabolic process (GO:1901160) | 3.34094726 |
| 75 | activation of protein kinase A activity (GO:0034199) | 3.33945533 |
| 76 | response to auditory stimulus (GO:0010996) | 3.31365148 |
| 77 | protein K11-linked deubiquitination (GO:0035871) | 3.31253113 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.31190866 |
| 79 | sodium ion export (GO:0071436) | 3.29905503 |
| 80 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.29203085 |
| 81 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28804170 |
| 82 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.27973782 |
| 83 | central nervous system neuron axonogenesis (GO:0021955) | 3.25809797 |
| 84 | positive regulation of vasculogenesis (GO:2001214) | 3.25803980 |
| 85 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23732761 |
| 86 | behavioral response to cocaine (GO:0048148) | 3.22889618 |
| 87 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22023898 |
| 88 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.22013858 |
| 89 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.21552343 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.20094299 |
| 91 | glycine transport (GO:0015816) | 3.19473332 |
| 92 | regulation of neurotransmitter secretion (GO:0046928) | 3.17691797 |
| 93 | neuronal ion channel clustering (GO:0045161) | 3.14532056 |
| 94 | regulation of dendritic spine development (GO:0060998) | 3.13623825 |
| 95 | reflex (GO:0060004) | 3.13486732 |
| 96 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12532629 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 3.11558292 |
| 98 | righting reflex (GO:0060013) | 3.11265444 |
| 99 | startle response (GO:0001964) | 3.10686644 |
| 100 | regulation of female receptivity (GO:0045924) | 3.10484233 |
| 101 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.10463358 |
| 102 | neural tube formation (GO:0001841) | 3.09227818 |
| 103 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.05413097 |
| 104 | detection of light stimulus involved in visual perception (GO:0050908) | 3.05413097 |
| 105 | regulation of glutamate secretion (GO:0014048) | 3.04295666 |
| 106 | positive regulation of dendritic spine development (GO:0060999) | 3.03816601 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 3.03049113 |
| 108 | regulation of vesicle fusion (GO:0031338) | 3.02760375 |
| 109 | amine catabolic process (GO:0009310) | 3.02276768 |
| 110 | cellular biogenic amine catabolic process (GO:0042402) | 3.02276768 |
| 111 | postsynaptic membrane organization (GO:0001941) | 3.01339821 |
| 112 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.00963477 |
| 113 | behavioral fear response (GO:0001662) | 3.00850966 |
| 114 | behavioral defense response (GO:0002209) | 3.00850966 |
| 115 | positive regulation of synapse maturation (GO:0090129) | 3.00739713 |
| 116 | adult walking behavior (GO:0007628) | 3.00379343 |
| 117 | neuron recognition (GO:0008038) | 3.00135355 |
| 118 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.97425758 |
| 119 | regulation of sarcomere organization (GO:0060297) | 2.97324072 |
| 120 | axon ensheathment in central nervous system (GO:0032291) | 2.97057818 |
| 121 | central nervous system myelination (GO:0022010) | 2.97057818 |
| 122 | NAD biosynthetic process (GO:0009435) | 2.96921842 |
| 123 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96410226 |
| 124 | membrane hyperpolarization (GO:0060081) | 2.95824847 |
| 125 | neuronal action potential (GO:0019228) | 2.95467497 |
| 126 | centrosome duplication (GO:0051298) | 2.93846433 |
| 127 | membrane depolarization (GO:0051899) | 2.93700668 |
| 128 | L-amino acid import (GO:0043092) | 2.92701604 |
| 129 | response to histamine (GO:0034776) | 2.92477366 |
| 130 | lipid translocation (GO:0034204) | 2.91954426 |
| 131 | phospholipid translocation (GO:0045332) | 2.91954426 |
| 132 | positive regulation of synaptic transmission (GO:0050806) | 2.91283941 |
| 133 | learning (GO:0007612) | 2.90189660 |
| 134 | dendritic spine organization (GO:0097061) | 2.89854793 |
| 135 | negative regulation of mast cell activation (GO:0033004) | 2.89743558 |
| 136 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89305675 |
| 137 | cell communication by electrical coupling (GO:0010644) | 2.88163987 |
| 138 | regulation of synaptic transmission (GO:0050804) | 2.87334938 |
| 139 | synaptic vesicle endocytosis (GO:0048488) | 2.85740463 |
| 140 | neuromuscular process (GO:0050905) | 2.85093866 |
| 141 | mating behavior (GO:0007617) | 2.85056930 |
| 142 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.84742000 |
| 143 | aromatic amino acid family catabolic process (GO:0009074) | 2.84403426 |
| 144 | ketone body metabolic process (GO:1902224) | 2.84184793 |
| 145 | negative regulation of type 2 immune response (GO:0002829) | 2.84136052 |
| 146 | dendrite morphogenesis (GO:0048813) | 2.83124842 |
| 147 | membrane depolarization during action potential (GO:0086010) | 2.82168332 |
| 148 | striatum development (GO:0021756) | 2.80674702 |
| 149 | signal peptide processing (GO:0006465) | 2.80434433 |
| 150 | inner ear receptor stereocilium organization (GO:0060122) | 2.80055178 |
| 151 | fear response (GO:0042596) | 2.79015864 |
| 152 | female mating behavior (GO:0060180) | 2.78636050 |
| 153 | negative regulation of dendrite development (GO:2000171) | 2.77880714 |
| 154 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77828860 |
| 155 | alanine transport (GO:0032328) | 2.76770339 |
| 156 | synaptic transmission, dopaminergic (GO:0001963) | 2.76288028 |
| 157 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75992985 |
| 158 | negative regulation of amino acid transport (GO:0051956) | 2.75829678 |
| 159 | synaptic transmission (GO:0007268) | 2.75825449 |
| 160 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.75596527 |
| 161 | retinal cone cell development (GO:0046549) | 2.73881502 |
| 162 | acrosome assembly (GO:0001675) | 2.71464543 |
| 163 | nucleoside diphosphate catabolic process (GO:0009134) | 2.69742660 |
| 164 | benzene-containing compound metabolic process (GO:0042537) | 2.69379581 |
| 165 | regulation of vasculogenesis (GO:2001212) | 2.68897264 |
| 166 | potassium ion transmembrane transport (GO:0071805) | 2.67012676 |
| 167 | cellular potassium ion transport (GO:0071804) | 2.67012676 |
| 168 | synaptic transmission, cholinergic (GO:0007271) | 2.65652818 |
| 169 | protein localization to cilium (GO:0061512) | 2.64917637 |
| 170 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.63846005 |
| 171 | tachykinin receptor signaling pathway (GO:0007217) | 2.63226090 |
| 172 | regulation of interleukin-13 production (GO:0032656) | 2.61888115 |
| 173 | establishment of protein localization to Golgi (GO:0072600) | 2.61259248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29069357 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08089406 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.02413438 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02268517 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00282246 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.98058190 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87407312 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68266541 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66520435 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66520435 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.63237580 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57327095 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55281678 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53730344 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.52078270 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.45580626 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43028693 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37516314 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.34945857 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32165440 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28850539 |
| 22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.24682300 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24535430 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.22649538 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.19430685 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19378917 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18862476 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14574043 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14022969 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09179036 |
| 31 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02433095 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.99113875 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93855415 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88499613 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.88240026 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.87001990 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86207292 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79734091 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77750363 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76315319 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76101434 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.68983837 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54652809 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53000025 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50883719 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48612356 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48612356 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47043441 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45895199 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45490078 |
| 51 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43549318 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41126818 |
| 53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41126818 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38547783 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38487671 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37936904 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36920717 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.33401104 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.32619517 |
| 60 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30733550 |
| 61 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28973634 |
| 62 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28539705 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27760956 |
| 64 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27031921 |
| 65 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26393275 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25937822 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25602070 |
| 68 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25292411 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24424970 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22789642 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22787573 |
| 72 | KDM2B_26808549_Chip-Seq_REH_Human | 1.21275935 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18409744 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18325372 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18266390 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17898254 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17897646 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.15859661 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15281169 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14599230 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14400613 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.13903967 |
| 83 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13844706 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13769743 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13499047 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12548549 |
| 87 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11356554 |
| 88 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10891611 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10773230 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10503512 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10476747 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09766323 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09756547 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08974138 |
| 95 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08070482 |
| 96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07394605 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07217500 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06641139 |
| 99 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.06548808 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05971226 |
| 101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05971226 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05813125 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05696025 |
| 104 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05426053 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05120984 |
| 106 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05105622 |
| 107 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.05036234 |
| 108 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04870837 |
| 109 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04653228 |
| 110 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03796447 |
| 111 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03757187 |
| 112 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02603199 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02562590 |
| 114 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01681995 |
| 115 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01631160 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01329217 |
| 117 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01258151 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01027006 |
| 119 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00393932 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99408440 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99120252 |
| 122 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.98906031 |
| 123 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98799286 |
| 124 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97062462 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96486513 |
| 126 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95699267 |
| 127 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95539414 |
| 128 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93204086 |
| 129 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93011967 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91513375 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90737577 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90490322 |
| 133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90248604 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90062325 |
| 135 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89874183 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89652252 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89613318 |
| 138 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87769962 |
| 139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86726534 |
| 140 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86418444 |
| 141 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86237325 |
| 142 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86054121 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85775373 |
| 144 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85339199 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85244157 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84779520 |
| 147 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83603520 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82708915 |
| 149 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81929669 |
| 150 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81642635 |
| 151 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81503877 |
| 152 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80649806 |
| 153 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80559828 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80517531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.86549121 |
| 2 | MP0002822_catalepsy | 4.68497569 |
| 3 | MP0003880_abnormal_central_pattern | 4.59598448 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.14719791 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.87471537 |
| 6 | MP0009745_abnormal_behavioral_response | 3.56672940 |
| 7 | MP0004270_analgesia | 3.50365585 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.36125705 |
| 9 | MP0002064_seizures | 3.18764337 |
| 10 | MP0009046_muscle_twitch | 2.86094409 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.74947849 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.71062437 |
| 13 | MP0001486_abnormal_startle_reflex | 2.59826581 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.52618402 |
| 15 | MP0002272_abnormal_nervous_system | 2.52126884 |
| 16 | MP0003329_amyloid_beta_deposits | 2.32791976 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.31584316 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.26826494 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.16169641 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.03919572 |
| 21 | MP0002736_abnormal_nociception_after | 1.99921301 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.92060980 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.90980128 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.80356673 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.80182277 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.78214159 |
| 27 | MP0001970_abnormal_pain_threshold | 1.72771721 |
| 28 | MP0008569_lethality_at_weaning | 1.69871632 |
| 29 | MP0004858_abnormal_nervous_system | 1.69414470 |
| 30 | MP0004924_abnormal_behavior | 1.67601593 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.67601593 |
| 32 | MP0003011_delayed_dark_adaptation | 1.66805115 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.65540359 |
| 34 | MP0004147_increased_porphyrin_level | 1.63707606 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.63491955 |
| 36 | MP0005253_abnormal_eye_physiology | 1.63124383 |
| 37 | MP0002102_abnormal_ear_morphology | 1.62667447 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.60591472 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.60221120 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.59227397 |
| 41 | MP0003879_abnormal_hair_cell | 1.54828501 |
| 42 | MP0001984_abnormal_olfaction | 1.53061380 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.52148783 |
| 44 | MP0001529_abnormal_vocalization | 1.50265855 |
| 45 | MP0003633_abnormal_nervous_system | 1.49702366 |
| 46 | MP0000427_abnormal_hair_cycle | 1.47437602 |
| 47 | MP0003646_muscle_fatigue | 1.45752886 |
| 48 | MP0003075_altered_response_to | 1.45340205 |
| 49 | MP0003690_abnormal_glial_cell | 1.43979174 |
| 50 | MP0004885_abnormal_endolymph | 1.43814466 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.42280295 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.40376250 |
| 53 | MP0000604_amyloidosis | 1.39332525 |
| 54 | MP0000955_abnormal_spinal_cord | 1.37711155 |
| 55 | MP0002184_abnormal_innervation | 1.36952340 |
| 56 | MP0005360_urolithiasis | 1.35525745 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.34846025 |
| 58 | MP0000778_abnormal_nervous_system | 1.34619489 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.28704457 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.26304152 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.25627231 |
| 62 | MP0001905_abnormal_dopamine_level | 1.25560561 |
| 63 | MP0003631_nervous_system_phenotype | 1.24008406 |
| 64 | MP0008872_abnormal_physiological_respon | 1.22778225 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.22272730 |
| 66 | MP0004142_abnormal_muscle_tone | 1.20719676 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.19706805 |
| 68 | MP0008874_decreased_physiological_sensi | 1.19023537 |
| 69 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13792896 |
| 70 | MP0005535_abnormal_body_temperature | 1.10117004 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.09032442 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.07175230 |
| 73 | MP0000371_diluted_coat_color | 1.06000152 |
| 74 | MP0001177_atelectasis | 1.05701600 |
| 75 | MP0005365_abnormal_bile_salt | 1.03622933 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 1.01468970 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.01295172 |
| 78 | MP0005171_absent_coat_pigmentation | 1.00914414 |
| 79 | MP0000920_abnormal_myelination | 1.00310318 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.99658998 |
| 81 | MP0002090_abnormal_vision | 0.96966370 |
| 82 | MP0008057_abnormal_DNA_replication | 0.96931602 |
| 83 | MP0003950_abnormal_plasma_membrane | 0.95420337 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.94576745 |
| 85 | MP0002229_neurodegeneration | 0.94031795 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.93385549 |
| 87 | MP0002152_abnormal_brain_morphology | 0.91755330 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.89539708 |
| 89 | MP0003632_abnormal_nervous_system | 0.88342665 |
| 90 | MP0005310_abnormal_salivary_gland | 0.88327723 |
| 91 | MP0000383_abnormal_hair_follicle | 0.87839884 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.87067405 |
| 93 | MP0003787_abnormal_imprinting | 0.84436713 |
| 94 | MP0005647_abnormal_sex_gland | 0.84110547 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 0.83790056 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.82462926 |
| 97 | MP0003136_yellow_coat_color | 0.82428299 |
| 98 | MP0005410_abnormal_fertilization | 0.81522739 |
| 99 | MP0002928_abnormal_bile_duct | 0.80066334 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.79761196 |
| 101 | MP0003634_abnormal_glial_cell | 0.79691013 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.78773883 |
| 103 | MP0000751_myopathy | 0.78249099 |
| 104 | MP0004085_abnormal_heartbeat | 0.76925121 |
| 105 | MP0005670_abnormal_white_adipose | 0.75429287 |
| 106 | MP0000026_abnormal_inner_ear | 0.74788746 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.71935297 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.70882801 |
| 109 | MP0003718_maternal_effect | 0.69515344 |
| 110 | MP0003119_abnormal_digestive_system | 0.69380960 |
| 111 | MP0003283_abnormal_digestive_organ | 0.68127878 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.67316563 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.66975532 |
| 114 | MP0003698_abnormal_male_reproductive | 0.66185472 |
| 115 | MP0005195_abnormal_posterior_eye | 0.64382732 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.64321080 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63871052 |
| 118 | MP0004130_abnormal_muscle_cell | 0.61679519 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.61606011 |
| 120 | MP0005166_decreased_susceptibility_to | 0.60241516 |
| 121 | * MP0002118_abnormal_lipid_homeostasis | 0.60140713 |
| 122 | MP0004043_abnormal_pH_regulation | 0.60135959 |
| 123 | MP0003122_maternal_imprinting | 0.58243270 |
| 124 | MP0001188_hyperpigmentation | 0.57956254 |
| 125 | MP0005332_abnormal_amino_acid | 0.57654265 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.57061314 |
| 127 | MP0005448_abnormal_energy_balance | 0.54995956 |
| 128 | MP0005499_abnormal_olfactory_system | 0.54359796 |
| 129 | MP0005394_taste/olfaction_phenotype | 0.54359796 |
| 130 | MP0001664_abnormal_digestion | 0.53999642 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.53924275 |
| 132 | MP0003195_calcinosis | 0.53848460 |
| 133 | MP0005409_darkened_coat_color | 0.53030342 |
| 134 | MP0004145_abnormal_muscle_electrophysio | 0.52335204 |
| 135 | MP0003252_abnormal_bile_duct | 0.52314876 |
| 136 | MP0002837_dystrophic_cardiac_calcinosis | 0.51577797 |
| 137 | MP0004742_abnormal_vestibular_system | 0.51335016 |
| 138 | MP0002752_abnormal_somatic_nervous | 0.51109562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.94154006 |
| 2 | Focal motor seizures (HP:0011153) | 7.49805025 |
| 3 | Focal seizures (HP:0007359) | 5.57810390 |
| 4 | Visual hallucinations (HP:0002367) | 4.76484535 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.38964792 |
| 6 | Atonic seizures (HP:0010819) | 4.00400354 |
| 7 | Generalized tonic-clonic seizures (HP:0002069) | 3.88656916 |
| 8 | Absence seizures (HP:0002121) | 3.86402194 |
| 9 | Febrile seizures (HP:0002373) | 3.81864772 |
| 10 | Action tremor (HP:0002345) | 3.76184075 |
| 11 | Pancreatic cysts (HP:0001737) | 3.65688488 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.59294785 |
| 13 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.58138719 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.57504191 |
| 15 | Torticollis (HP:0000473) | 3.56284450 |
| 16 | Poor eye contact (HP:0000817) | 3.55714163 |
| 17 | Dialeptic seizures (HP:0011146) | 3.55497889 |
| 18 | Ankle clonus (HP:0011448) | 3.50156624 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.47973815 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.38648243 |
| 21 | Pancreatic fibrosis (HP:0100732) | 3.36658177 |
| 22 | Postural instability (HP:0002172) | 3.36218033 |
| 23 | Abnormal social behavior (HP:0012433) | 3.35593315 |
| 24 | Impaired social interactions (HP:0000735) | 3.35593315 |
| 25 | Prostate neoplasm (HP:0100787) | 3.32851616 |
| 26 | Depression (HP:0000716) | 3.31476703 |
| 27 | Focal dystonia (HP:0004373) | 3.30864069 |
| 28 | Anxiety (HP:0000739) | 3.29392106 |
| 29 | Dysmetria (HP:0001310) | 3.27589975 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.24897553 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 3.24163427 |
| 32 | True hermaphroditism (HP:0010459) | 3.21707579 |
| 33 | Hyperventilation (HP:0002883) | 3.17077404 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 3.14937744 |
| 35 | Pendular nystagmus (HP:0012043) | 3.12089464 |
| 36 | Broad-based gait (HP:0002136) | 3.10432349 |
| 37 | Craniofacial dystonia (HP:0012179) | 3.07889075 |
| 38 | Status epilepticus (HP:0002133) | 3.06917410 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 3.05111658 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.93233539 |
| 41 | Intention tremor (HP:0002080) | 2.91179431 |
| 42 | Congenital stationary night blindness (HP:0007642) | 2.91173143 |
| 43 | Spastic gait (HP:0002064) | 2.84532981 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.81890751 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.81890751 |
| 46 | Urinary urgency (HP:0000012) | 2.76049724 |
| 47 | Protruding tongue (HP:0010808) | 2.75302394 |
| 48 | Papilledema (HP:0001085) | 2.71907799 |
| 49 | Nephronophthisis (HP:0000090) | 2.71728361 |
| 50 | Scanning speech (HP:0002168) | 2.70651045 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.69784397 |
| 52 | Hemiplegia (HP:0002301) | 2.64383710 |
| 53 | Mutism (HP:0002300) | 2.61929628 |
| 54 | Annular pancreas (HP:0001734) | 2.61130920 |
| 55 | Clumsiness (HP:0002312) | 2.59557594 |
| 56 | Bradykinesia (HP:0002067) | 2.58684276 |
| 57 | Abnormality of macular pigmentation (HP:0008002) | 2.58616710 |
| 58 | Truncal ataxia (HP:0002078) | 2.58414746 |
| 59 | Amblyopia (HP:0000646) | 2.58088273 |
| 60 | Megalencephaly (HP:0001355) | 2.57382227 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.56447856 |
| 62 | Abolished electroretinogram (ERG) (HP:0000550) | 2.55540268 |
| 63 | Congenital sensorineural hearing impairment (HP:0008527) | 2.52987751 |
| 64 | Increased corneal curvature (HP:0100692) | 2.52448846 |
| 65 | Keratoconus (HP:0000563) | 2.52448846 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.49865850 |
| 67 | Stereotypic behavior (HP:0000733) | 2.47403193 |
| 68 | Fair hair (HP:0002286) | 2.46993958 |
| 69 | Abnormality of the renal cortex (HP:0011035) | 2.45503585 |
| 70 | Cystic liver disease (HP:0006706) | 2.43912057 |
| 71 | Abnormality of the hepatic vasculature (HP:0006707) | 2.43160063 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42568687 |
| 73 | Hemiparesis (HP:0001269) | 2.42514704 |
| 74 | Abnormality of the renal medulla (HP:0100957) | 2.39337680 |
| 75 | Generalized myoclonic seizures (HP:0002123) | 2.37219196 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.35558888 |
| 77 | Decreased central vision (HP:0007663) | 2.34770710 |
| 78 | Chronic hepatic failure (HP:0100626) | 2.33777188 |
| 79 | Impaired smooth pursuit (HP:0007772) | 2.33589020 |
| 80 | Deep venous thrombosis (HP:0002625) | 2.31283470 |
| 81 | Severe visual impairment (HP:0001141) | 2.30653380 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 2.28892077 |
| 83 | Excessive salivation (HP:0003781) | 2.28641054 |
| 84 | Drooling (HP:0002307) | 2.28641054 |
| 85 | Ventricular fibrillation (HP:0001663) | 2.26760420 |
| 86 | Progressive inability to walk (HP:0002505) | 2.26158126 |
| 87 | Dysmetric saccades (HP:0000641) | 2.25949050 |
| 88 | Clonus (HP:0002169) | 2.25586361 |
| 89 | Resting tremor (HP:0002322) | 2.23365225 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 2.22896118 |
| 91 | Genetic anticipation (HP:0003743) | 2.21351248 |
| 92 | Lower limb muscle weakness (HP:0007340) | 2.21294497 |
| 93 | Type II lissencephaly (HP:0007260) | 2.14728497 |
| 94 | Tetraplegia (HP:0002445) | 2.13413778 |
| 95 | Termporal pattern (HP:0011008) | 2.13039308 |
| 96 | Insidious onset (HP:0003587) | 2.13039308 |
| 97 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.11868564 |
| 98 | Diplopia (HP:0000651) | 2.08257721 |
| 99 | Abnormality of binocular vision (HP:0011514) | 2.08257721 |
| 100 | Chorioretinal atrophy (HP:0000533) | 2.08054848 |
| 101 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.07947499 |
| 102 | Gait imbalance (HP:0002141) | 2.06653020 |
| 103 | Limb ataxia (HP:0002070) | 2.02114846 |
| 104 | Generalized hypopigmentation of hair (HP:0011358) | 2.02016272 |
| 105 | Rigidity (HP:0002063) | 2.01323033 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 2.00401633 |
| 107 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00144710 |
| 108 | Absent/shortened dynein arms (HP:0200106) | 1.99270992 |
| 109 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99270992 |
| 110 | Retinitis pigmentosa (HP:0000510) | 1.96959204 |
| 111 | Postural tremor (HP:0002174) | 1.96653832 |
| 112 | Delusions (HP:0000746) | 1.95450370 |
| 113 | Incomplete penetrance (HP:0003829) | 1.94953523 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.94183065 |
| 115 | Abnormality of the periventricular white matter (HP:0002518) | 1.93992621 |
| 116 | Bundle branch block (HP:0011710) | 1.93047263 |
| 117 | Spastic tetraparesis (HP:0001285) | 1.92811544 |
| 118 | Pointed chin (HP:0000307) | 1.92177105 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.91808034 |
| 120 | Gait ataxia (HP:0002066) | 1.91083063 |
| 121 | Polyphagia (HP:0002591) | 1.90918658 |
| 122 | Abnormal drinking behavior (HP:0030082) | 1.90829084 |
| 123 | Polydipsia (HP:0001959) | 1.90829084 |
| 124 | Tubular atrophy (HP:0000092) | 1.90239004 |
| 125 | Blue irides (HP:0000635) | 1.90032324 |
| 126 | Ankyloglossia (HP:0010296) | 1.89898870 |
| 127 | Sclerocornea (HP:0000647) | 1.89392448 |
| 128 | Fetal akinesia sequence (HP:0001989) | 1.89237536 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87322200 |
| 130 | Insomnia (HP:0100785) | 1.87297334 |
| 131 | Hyperlipoproteinemia (HP:0010980) | 1.86505192 |
| 132 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86418523 |
| 133 | Inability to walk (HP:0002540) | 1.86125194 |
| 134 | Lower limb amyotrophy (HP:0007210) | 1.85924826 |
| 135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.85680131 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.84818953 |
| 137 | Cholecystitis (HP:0001082) | 1.84818953 |
| 138 | Pheochromocytoma (HP:0002666) | 1.84678050 |
| 139 | Absent speech (HP:0001344) | 1.83387711 |
| 140 | Limb dystonia (HP:0002451) | 1.83111442 |
| 141 | Abnormal ciliary motility (HP:0012262) | 1.82359490 |
| 142 | Widely spaced teeth (HP:0000687) | 1.81901000 |
| 143 | Psychosis (HP:0000709) | 1.81511499 |
| 144 | Delayed CNS myelination (HP:0002188) | 1.79973385 |
| 145 | Aplasia involving bones of the extremities (HP:0009825) | 1.78947622 |
| 146 | Aplasia of the phalanges of the hand (HP:0009802) | 1.78947622 |
| 147 | Congenital primary aphakia (HP:0007707) | 1.78508347 |
| 148 | Central scotoma (HP:0000603) | 1.78061275 |
| 149 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75719916 |
| 150 | Oculomotor apraxia (HP:0000657) | 1.75096087 |
| 151 | Furrowed tongue (HP:0000221) | 1.74166790 |
| 152 | Abnormality of alanine metabolism (HP:0010916) | 1.71523448 |
| 153 | Hyperalaninemia (HP:0003348) | 1.71523448 |
| 154 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71523448 |
| 155 | Bile duct proliferation (HP:0001408) | 1.69614426 |
| 156 | Abnormal biliary tract physiology (HP:0012439) | 1.69614426 |
| 157 | Genital tract atresia (HP:0001827) | 1.68508116 |
| 158 | Small hand (HP:0200055) | 1.67162974 |
| 159 | Renal cortical cysts (HP:0000803) | 1.66306246 |
| 160 | Cerebellar dysplasia (HP:0007033) | 1.63537476 |
| 161 | Congenital hepatic fibrosis (HP:0002612) | 1.63476746 |
| 162 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.60559269 |
| 163 | Macroglossia (HP:0000158) | 1.59527281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 8.46865095 |
| 2 | EPHA4 | 5.98760345 |
| 3 | NTRK3 | 4.26875106 |
| 4 | MAP3K9 | 3.84406094 |
| 5 | DAPK2 | 3.22011042 |
| 6 | BMPR1B | 2.68820035 |
| 7 | ACVR1B | 2.65857025 |
| 8 | KSR2 | 2.48094798 |
| 9 | MAP3K4 | 2.43765409 |
| 10 | PRKD3 | 2.40638313 |
| 11 | MINK1 | 2.39843398 |
| 12 | PAK6 | 2.34606854 |
| 13 | MARK1 | 2.17767953 |
| 14 | NTRK2 | 2.07319734 |
| 15 | CAMKK1 | 2.05071192 |
| 16 | MAP2K7 | 1.96909866 |
| 17 | NTRK1 | 1.94281879 |
| 18 | ADRBK2 | 1.91405400 |
| 19 | WNK3 | 1.85347299 |
| 20 | RIPK4 | 1.84572914 |
| 21 | GRK1 | 1.79882542 |
| 22 | MAP2K4 | 1.79868762 |
| 23 | MAP3K13 | 1.68798822 |
| 24 | DAPK1 | 1.67479066 |
| 25 | TNIK | 1.64452837 |
| 26 | ARAF | 1.62245715 |
| 27 | KSR1 | 1.58520593 |
| 28 | CDK5 | 1.58370514 |
| 29 | MKNK2 | 1.47729692 |
| 30 | PRPF4B | 1.40434081 |
| 31 | STK38 | 1.37940966 |
| 32 | MAP4K2 | 1.31567600 |
| 33 | FES | 1.31534695 |
| 34 | TAOK1 | 1.31495417 |
| 35 | INSRR | 1.30062659 |
| 36 | TYRO3 | 1.29769803 |
| 37 | MAP3K12 | 1.29116382 |
| 38 | MAP3K2 | 1.28247870 |
| 39 | SIK2 | 1.24610124 |
| 40 | PRKCG | 1.22393883 |
| 41 | GRK5 | 1.20883419 |
| 42 | PINK1 | 1.20264218 |
| 43 | CDK19 | 1.18893929 |
| 44 | ZAK | 1.17954329 |
| 45 | NUAK1 | 1.14304924 |
| 46 | PLK2 | 1.10434271 |
| 47 | STK39 | 1.07037473 |
| 48 | TAOK3 | 1.05577502 |
| 49 | STK38L | 1.03685077 |
| 50 | UHMK1 | 1.02025522 |
| 51 | SGK494 | 0.97925221 |
| 52 | SGK223 | 0.97925221 |
| 53 | CAMKK2 | 0.96706093 |
| 54 | PRKCH | 0.95234703 |
| 55 | ADRBK1 | 0.94918056 |
| 56 | RAF1 | 0.94546125 |
| 57 | CAMK1 | 0.94166618 |
| 58 | BCR | 0.93223542 |
| 59 | CASK | 0.93205672 |
| 60 | STK11 | 0.93153049 |
| 61 | CAMK2A | 0.92483761 |
| 62 | TXK | 0.91593816 |
| 63 | MAPK13 | 0.91578997 |
| 64 | CDK15 | 0.88632476 |
| 65 | CDK18 | 0.88353582 |
| 66 | WNK4 | 0.83274879 |
| 67 | PTK2B | 0.82983484 |
| 68 | CDK14 | 0.82727451 |
| 69 | TRIM28 | 0.82105225 |
| 70 | CAMK2B | 0.79235482 |
| 71 | PNCK | 0.78134071 |
| 72 | OXSR1 | 0.77305405 |
| 73 | PDPK1 | 0.76910847 |
| 74 | PHKG2 | 0.76672603 |
| 75 | PHKG1 | 0.76672603 |
| 76 | CDK11A | 0.76238286 |
| 77 | SGK2 | 0.75827459 |
| 78 | RET | 0.75587334 |
| 79 | PAK3 | 0.75396065 |
| 80 | PDK1 | 0.75247731 |
| 81 | MAP3K1 | 0.74547976 |
| 82 | SGK3 | 0.73502341 |
| 83 | ALK | 0.73058606 |
| 84 | TGFBR1 | 0.72869365 |
| 85 | TNK2 | 0.72404990 |
| 86 | LMTK2 | 0.71679919 |
| 87 | SGK1 | 0.70785177 |
| 88 | LATS2 | 0.70641357 |
| 89 | BMPR2 | 0.70542436 |
| 90 | STK3 | 0.70284110 |
| 91 | MARK2 | 0.69200547 |
| 92 | PRKCZ | 0.62026567 |
| 93 | CSNK1G2 | 0.59384147 |
| 94 | MAP3K7 | 0.59085558 |
| 95 | PKN1 | 0.56670673 |
| 96 | MAPKAPK5 | 0.56502958 |
| 97 | DAPK3 | 0.54543839 |
| 98 | CAMK2G | 0.54393925 |
| 99 | NEK6 | 0.54368723 |
| 100 | RPS6KA3 | 0.53710758 |
| 101 | MKNK1 | 0.53679937 |
| 102 | DYRK1A | 0.53172535 |
| 103 | PIK3CG | 0.52957166 |
| 104 | MAP2K1 | 0.50076156 |
| 105 | NEK1 | 0.49820760 |
| 106 | CAMK4 | 0.49114077 |
| 107 | PIK3CA | 0.48350247 |
| 108 | FGFR2 | 0.47532021 |
| 109 | RIPK1 | 0.47282218 |
| 110 | BRSK1 | 0.46551241 |
| 111 | FYN | 0.45365449 |
| 112 | AKT3 | 0.43465614 |
| 113 | ERBB2 | 0.41634253 |
| 114 | PRKAA2 | 0.41298946 |
| 115 | CAMK2D | 0.40910297 |
| 116 | MAPK10 | 0.39759343 |
| 117 | CSNK1A1L | 0.39014946 |
| 118 | FGR | 0.38797895 |
| 119 | PRKCE | 0.38685209 |
| 120 | ICK | 0.38295068 |
| 121 | PRKG1 | 0.38088252 |
| 122 | CSNK1D | 0.37849083 |
| 123 | CSNK1G1 | 0.37586484 |
| 124 | CDC42BPA | 0.37054874 |
| 125 | CAMK1G | 0.36411629 |
| 126 | BRAF | 0.35648215 |
| 127 | PRKACA | 0.35626767 |
| 128 | TEC | 0.33739684 |
| 129 | MAPK12 | 0.33510916 |
| 130 | CSNK1A1 | 0.32752947 |
| 131 | PRKCA | 0.32675247 |
| 132 | PRKCB | 0.31664458 |
| 133 | CSNK1G3 | 0.31011634 |
| 134 | MOS | 0.30489863 |
| 135 | PRKACG | 0.30334676 |
| 136 | PRKAA1 | 0.30073831 |
| 137 | FER | 0.27721005 |
| 138 | MAP2K6 | 0.26948148 |
| 139 | MUSK | 0.25764718 |
| 140 | MAPKAPK3 | 0.24702595 |
| 141 | DYRK2 | 0.24101332 |
| 142 | TIE1 | 0.24018425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.29936888 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09008057 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.98108568 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79551615 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63887138 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50089607 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42309199 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36975877 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.36695532 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.34756529 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.29736679 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.29280322 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.00591882 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91730650 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.90693383 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84852076 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.82014937 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76173722 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.75651456 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73938054 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70698141 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.69144218 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68462443 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68320712 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63168503 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.53944039 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.49724088 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.48761921 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47852368 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47513956 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45130277 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43852928 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41609789 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.36900752 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32924273 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32285909 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.30858964 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.28116692 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21232726 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20487229 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18983282 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18405288 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14037295 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13765755 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13592694 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13224836 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12925322 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 1.09410392 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07729434 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07599126 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04520794 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03670546 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00224098 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00095417 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99387862 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97656938 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96672215 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91627343 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.89747666 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87399477 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86831021 |
| 62 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84009502 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83979927 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83454676 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81608521 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.80447949 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79349954 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.77905478 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77114888 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76064008 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.74434526 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74420763 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73881577 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69336171 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68755298 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68292329 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67244795 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64448351 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63999643 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61877899 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61618488 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61517508 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61363071 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59617023 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58803388 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58539016 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58058708 |
| 88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56483342 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55198406 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54415311 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.54384951 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53826662 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53809204 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51408782 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51249777 |
| 96 | RNA polymerase_Homo sapiens_hsa03020 | 0.49978818 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49795839 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49105504 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48901649 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48714021 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48638708 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47646481 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47129666 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43844923 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43017918 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.42728383 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.40551057 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40026406 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.39108407 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39074489 |
| 111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39048281 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38723718 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38316422 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37955280 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36637234 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35576029 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34926732 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34517010 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34507112 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34479230 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34148055 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33946934 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33147556 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.32114350 |
| 125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30771085 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30563008 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30324011 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29888157 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29764203 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.29431781 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29356363 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28897396 |
| 133 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28870733 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28848729 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28637176 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.27326023 |

